Recognized biomarkers of AD in CSF like Amyloid β peptide (AβP), Apolipoprotein E (ApoE), and total tau (t-tau) proteins are highly accurate and well-characterized for sensitive and specific detection. This evidence concerns the gene MAPT and Alzheimer disease.